AnaptysBio, Inc. financial statements
AnaptysBio, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 234.6M | 10-KT |
| Net income | −USD 13.23M | 10-KT |
| Cash and equivalents | USD 138.2M | 10-KT |
| Total debt | USD 14.11M | EODHD |
AnaptysBio, Inc. financials on 6ix · AnaptysBio, Inc. on 6ix